Cite

HARVARD Citation

    Dietrich, P. et al. (n.d.). OS2.2 Highly personalized peptide vaccination for patients with newly diagnosed glioblastoma: the GAPVAC trial. Neuro-oncology. p. iii219. [Online]. 
  
Back to record